A critical advance in cancer study is arising with the use of mini-antibodies to reactivate damaged p53. This vital tumor suppressor protein is frequently disabled in many types of cancer, causing uncontrolled tissue https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research